Graves' orbitopathy treated with immunosuppressive therapy and orbital radiotherapy in a tertiary care endocrine centre: case series

Graves’ Orbitopathy (GO) is a localized entity of Graves’ disease, which is a challenging disease to treat. We describe 6 cases of moderate to severe GO who presented to our endocrine centre, with a mean age of 48.6 years and equal gender distribution. All of them were thyrotoxic before the presentation and were treated with antithyroid drugs. CT scans of orbits in 5 patients were consistent with GO. All of the patients were treated with intravenous methylprednisolone pulse therapy for a duration of 12 weeks and orbital radiotherapy for two weeks according to European Groups on Graves' Orbitopathy (EUGOGO) guideline. All six patients went into remission and remained so after one year of follow-up. Combination therapy seems to be effective in treating moderate to severe GO.

• Publication year

  2016

• Venue

  Sri Lanka Journal of Diabetes Endocrinology and Metabolism

• Publication date

  2016-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.4038/sjdem.v6i2.7314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

  2016influential reference
• Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.

  2014cited by this paper
• Disease Activity in Graves' Ophthalmopathy: Diagnosis with Orbital MR Imaging and Correlation with Clinical Score

  2013cited by this paper
• Orbital radiotherapy for adult thyroid eye disease.

  2012cited by this paper
• Thyroid associated orbitopathy

  2012cited by this paper
• Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy

  2012cited by this paper
• Epidemiology of Graves' orbitopathy.

  2010cited by this paper
• Age Influences the Severity of Graves' Ophthalmopathy

  2008cited by this paper
• Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.

  2006influential reference
• Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy.

  2005cited by this paper
• Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.

  2004cited by this paper
• Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy

  2000cited by this paper
• Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy

  1997cited by this paper
• Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.

  1989cited by this paper
• Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism

  1989cited by this paper

• No citing papers are available for this paper.